BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30421824)

  • 1. Salivary duct carcinoma: Prospective multicenter study of 61 cases of the Réseau d'Expertise Français des Cancers ORL Rares.
    Villepelet A; Lefèvre M; Verillaud B; Janot F; Garrel R; Vergez S; Bertolus C; Malard O; de Gabory L; Mauvais O; Baujat B;
    Head Neck; 2019 Mar; 41(3):584-591. PubMed ID: 30421824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucoepidermoid carcinoma of salivary glands: A French Network of Rare Head and Neck Tumors (REFCOR) prospective study of 292 cases.
    Dahan LS; Giorgi R; Vergez S; Le Taillandier de Gabory L; Costes-Martineau V; Herman P; Poissonnet G; Mauvais O; Malard O; Garrel R; Uro-Coste E; Barry B; Bach C; Chevalier D; Mouawad F; Merol JC; Bastit V; Thariat J; Gilain L; Dufour X; Righini CA; Moya-Plana A; Even C; Radulesco T; Michel J; Baujat B; Fakhry N;
    Eur J Surg Oncol; 2021 Jun; 47(6):1376-1383. PubMed ID: 33248902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head and neck adenoid cystic carcinoma: A prospective multicenter REFCOR study of 95 cases.
    Meyers M; Granger B; Herman P; Janot F; Garrel R; Fakhry N; Poissonnet G; Baujat B;
    Eur Ann Otorhinolaryngol Head Neck Dis; 2016 Feb; 133(1):13-7. PubMed ID: 26493113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.
    Gilbert MR; Sharma A; Schmitt NC; Johnson JT; Ferris RL; Duvvuri U; Kim S
    JAMA Otolaryngol Head Neck Surg; 2016 May; 142(5):489-95. PubMed ID: 26939990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands.
    Boon E; Bel M; van Boxtel W; van der Graaf WTA; van Es RJJ; Eerenstein SEJ; Baatenburg de Jong RJ; van den Brekel MWM; van der Velden LA; Witjes MJH; Hoeben A; Willems SM; Bloemena E; Smit LA; Oosting SF; ; Jonker MA; Flucke UE; van Herpen CML
    Int J Cancer; 2018 Aug; 143(4):758-766. PubMed ID: 29492965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis.
    Haderlein M; Scherl C; Semrau S; Lettmaier S; Hecht M; Erber R; Iro H; Fietkau R; Agaimy A
    Strahlenther Onkol; 2017 Nov; 193(11):961-970. PubMed ID: 28828496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of lymph node density in high-grade salivary gland cancers.
    Hong HR; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2015 May; 111(6):784-9. PubMed ID: 25640975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage as major long term outcome predictor in minor salivary gland carcinoma.
    Vander Poorten VL; Balm AJ; Hilgers FJ; Tan IB; Keus RB; Hart AA
    Cancer; 2000 Sep; 89(6):1195-204. PubMed ID: 11002213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of Care and Outcome of Clear Cell Carcinoma of the Head and Neck.
    Oliver J; Wu P; Chang C; Roden D; Wang B; Liu C; Hu K; Schreiber D; Givi B
    Otolaryngol Head Neck Surg; 2019 Jul; 161(1):98-104. PubMed ID: 30857486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary salivary gland-type lung cancer: clinicopathological analysis of 88 cases from China.
    Zhu F; Liu Z; Hou Y; He D; Ge X; Bai C; Jiang L; Li S
    J Thorac Oncol; 2013 Dec; 8(12):1578-84. PubMed ID: 24389442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management and outcome of patients with malignant salivary gland tumors.
    Bell RB; Dierks EJ; Homer L; Potter BE
    J Oral Maxillofac Surg; 2005 Jul; 63(7):917-28. PubMed ID: 16003616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients.
    Williams MD; Roberts D; Blumenschein GR; Temam S; Kies MS; Rosenthal DI; Weber RS; El-Naggar AK
    Am J Surg Pathol; 2007 Nov; 31(11):1645-52. PubMed ID: 18059220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary duct carcinoma: evaluation of treatment and outcome in a tertiary referral institute.
    Beck ACC; Lohuis PJFM; Al-Mamgani A; Smit LA; Klop WMC
    Eur Arch Otorhinolaryngol; 2018 Jul; 275(7):1885-1892. PubMed ID: 29785551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in patients with minor salivary gland carcinoma of the oral cavity and oropharynx.
    Carrillo JF; Maldonado F; Carrillo LC; Ramirez-Ortega MC; Pizano JG; Melo C; Chanona JG; Luna-Ortiz K; Ocaña LF
    Head Neck; 2011 Oct; 33(10):1406-12. PubMed ID: 21928413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant expression of ezrin and HER2 predicts distant metastasis and poor prognosis of patients with salivary gland carcinomas.
    Hashimoto K; Hayashi R; Mukaigawa T; Yamazaki M; Fujii S
    Hum Pathol; 2017 May; 63():110-119. PubMed ID: 28300573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical analysis of 37 cases with lymphoepithelial carcinoma of the major salivary gland treated by surgical resection and postoperative radiotherapy: a single institution study.
    Li F; Zhu G; Wang Y; Wang Y; Chen T; Ji Q
    Med Oncol; 2014 May; 31(5):957. PubMed ID: 24715369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors and outcome analysis of salivary duct carcinoma.
    Han MW; Roh JL; Choi SH; Nam SY; Lee HJ; Cho KJ; Lee SW; Kim SY
    Auris Nasus Larynx; 2015 Dec; 42(6):472-7. PubMed ID: 26028371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of surgery and post-operative radiotherapy for major salivary gland carcinoma: ten year experience from a single institute.
    Kaur J; Goyal S; Muzumder S; Bhasker S; Mohanti BK; Rath GK
    Asian Pac J Cancer Prev; 2014; 15(19):8259-63. PubMed ID: 25339015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary duct carcinoma: a Danish national study.
    Breinholt H; Elhakim MT; Godballe C; Andersen LJ; Primdahl H; Kristensen CA; Bjørndal K
    J Oral Pathol Med; 2016 Oct; 45(9):664-671. PubMed ID: 26822194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of PSMA, c-MET and E-cadherin in salivary duct carcinoma.
    van Boxtel W; Uijen MJM; Verhaegh GW; Willems SM; Jonker MA; ; Schalken JA; van Engen-van Grunsven ICH; van Herpen CML
    Oral Oncol; 2020 Nov; 110():105018. PubMed ID: 33039794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.